Immunization, Hib3 in Tajikistan
Tajikistan: Immunization, Hib3 was 97.0% in 2024. ▲ Rising
Immunization, Hib3 in Tajikistan, 2008–2024
Source: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Measured in % of children ages 12-23 months.
Analysis
In 2024, immunization, hib3 in Tajikistan stood at 97.0%. That is the highest value across all 17 years on record.
That represents a change of up 1.0% on the previous year and unchanged over ten years.
Over the whole period, immunization, hib3 in Tajikistan peaked at 97.0% in 2014 and was at its lowest, 46.0%, in 2008.
Tajikistan ranks 29th of 191 countries on this measure, in the top quarter.
The long-run direction has been consistently rising across the 17 years of available data.
Immunization, Hib3 in Tajikistan, year by year
| Year | % of children ages 12-23 months | Change |
|---|---|---|
| 2008 | 46.0% | — |
| 2009 | 93.0% | +102.2% |
| 2010 | 93.0% | +0.0% |
| 2011 | 96.0% | +3.2% |
| 2012 | 94.0% | -2.1% |
| 2013 | 96.0% | +2.1% |
| 2014 | 97.0% | +1.0% |
| 2015 | 96.0% | -1.0% |
| 2016 | 97.0% | +1.0% |
| 2017 | 97.0% | +0.0% |
| 2018 | 96.0% | -1.0% |
| 2019 | 97.0% | +1.0% |
| 2020 | 97.0% | +0.0% |
| 2021 | 97.0% | +0.0% |
| 2022 | 97.0% | +0.0% |
| 2023 | 96.0% | -1.0% |
| 2024 | 97.0% | +1.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 69.5% | 46.0% | 93.0% | 2 |
| 2010s | 95.9% | 93.0% | 97.0% | 10 |
| 2020s | 96.8% | 96.0% | 97.0% | 5 |
Countries ranked near Tajikistan
- 29 Albania 97.0% compare
- 29 Bangladesh 97.0% compare
- 29 Belgium 97.0% compare
- 29 Egypt 97.0% compare
- 29 Korea 97.0% compare
- 29 Latvia 97.0% compare
- 29 Malta 97.0% compare
- 29 Naoero 97.0% compare
- 29 Nepal 97.0% compare
- 29 Norway 97.0% compare
- 29 Saudi Arabia 97.0% compare
- 29 Singapore 97.0% compare
- 29 Sri Lanka 97.0% compare
- 29 Saint Kitts and Nevis 97.0% compare
- 29 Tunisia 97.0% compare
- 29 Viet Nam 97.0% compare
More health data for Tajikistan
- Un projection of annual infant deaths, annual growth rate -1.94 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.9561 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 887 deaths per 1,000 people (2090)
- Number of infants who die before age 1 1,061 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2021)
- Population ages 00-04, female, annual growth rate -0.6758 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0596 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.6416 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is immunization, hib3 in Tajikistan?
- Immunization, hib3 in Tajikistan was 97.0% in 2024, according to WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).
- What is the highest immunization, hib3 recorded in Tajikistan?
- The highest recorded value was 97.0% in 2014.
- What is the lowest immunization, hib3 recorded in Tajikistan?
- The lowest recorded value was 46.0% in 2008.
- How does Tajikistan rank for immunization, hib3?
- Tajikistan ranks 29th out of 191 countries with data for 2024.
- Is immunization, hib3 rising or falling in Tajikistan?
- Over the last ten years it is unchanged. The long-run trend across the full record is rising.
- Where does this Tajikistan data come from?
- The figures come from WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as part of Immunization, Hib3 (% of children ages 12-23 months). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 17 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.